Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.

Knudsen TA, Hansen DL, Ocias LF, Bjerrum OW, Brabrand M, Christensen SF, Eickhardt-Dalbøge CS, Ellervik C, El Fassi D, Frederiksen M, Kjær L, Kristensen TK, Kruse TA, Larsen MK, Mourits-Andersen T, Möller S, Overgaard UM, Severinsen MT, Skov V, Sørensen AL, Stentoft J, Starklint J, de Stricker K, Thomassen M, Larsen TS, Hasselbalch HC

Open source

DOI: 10.1016/j.eclinm.2026.104193
Published: 2026 Oct
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104193,
  title = {Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.},
  author = {Knudsen TA and Hansen DL and Ocias LF and Bjerrum OW and Brabrand M and Christensen SF and Eickhardt-Dalbøge CS and Ellervik C and El Fassi D and Frederiksen M and Kjær L and Kristensen TK and Kruse TA and Larsen MK and Mourits-Andersen T and Möller S and Overgaard UM and Severinsen MT and Skov V and Sørensen AL and Stentoft J and Starklint J and de Stricker K and Thomassen M and Larsen TS and Hasselbalch HC},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104193},
  url = {https://doi.org/10.1016/j.eclinm.2026.104193}
}

RIS

TY  - JOUR
TI  - Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.
AU  - Knudsen TA
AU  - Hansen DL
AU  - Ocias LF
AU  - Bjerrum OW
AU  - Brabrand M
AU  - Christensen SF
AU  - Eickhardt-Dalbøge CS
AU  - Ellervik C
AU  - El Fassi D
AU  - Frederiksen M
AU  - Kjær L
AU  - Kristensen TK
AU  - Kruse TA
AU  - Larsen MK
AU  - Mourits-Andersen T
AU  - Möller S
AU  - Overgaard UM
AU  - Severinsen MT
AU  - Skov V
AU  - Sørensen AL
AU  - Stentoft J
AU  - Starklint J
AU  - de Stricker K
AU  - Thomassen M
AU  - Larsen TS
AU  - Hasselbalch HC
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104193
UR  - https://doi.org/10.1016/j.eclinm.2026.104193
ER  -

APA

TA, K., DL, H., LF, O., OW, B., M, B., SF, C., CS, E., C, E., D, E. F., M, F., L, K., TK, K., TA, K., MK, L., T, M., S, M., UM, O., MT, S., V, S., AL, S., J, S., J, S., K, D. S., M, T., TS, L., & HC, H. (2026). Interferon-α vs hydroxyurea in patients with myeloproliferative neoplasms (DALIAH): a multicentre, randomised, open-label, phase 3 trial in Denmark.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104193

Source records

pubmed · retrieved 2026-09-25T20:00:42.378Z